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Abstract 
Background: Modulated electro-hyperthermia (mEHT), a non-invasive intervention using 13.56 
MHz radiofrequency, can selectively target cancers due to their elevated glycolysis 
(Warburg-effect), extracellular ion concentration and conductivity compared to normal tissues. We 
showed earlier that mEHT alone can provoke apoptosis and damage associated molecular pattern 
(DAMP) signals in human HT29 colorectal cancer xenografts of immunocompromised mice.  
Materials: Here we tested the mEHT induced stress and immune responses in C26 colorectal 
cancer allografts of immunocompetent (BALB/c) mice between 12-72 h post-treatment. The right 
side of the symmetrical tumors grown in both femoral regions of mice were treated for 30 minutes, 
while the left side tumors served for untreated controls. 
Results: Loco-regional mEHT treatment induced an ongoing and significant tumor damage with the 
blockade of cell cycle progression indicated by the loss of nuclear Ki67 protein. Nuclear shrinkage, 
apoptotic bodies and DNA fragmentation detected using TUNEL assay confirmed apoptosis. 
Cleaved/activated-caspase-8 and -caspase-3 upregulation along with mitochondrial translocation of 
bax protein and release of cytochrome-c were consistent with the activation of both the extrinsic 
and intrinsic caspase-dependent programmed cell death pathways. The prominent release of 
stress-associated Hsp70, calreticulin and HMGB1 proteins, relevant to DAMP signaling, was 
accompanied by the significant tumor infiltration by S100 positive antigen presenting dendritic cells 
and CD3 positive T-cells with only scant FoxP3 positive regulatory T-cells. In addition, mEHT 
combined with a chlorogenic acid rich T-cell promoting agent induced significant cell death both in 
the treated and the untreated contralateral tumors indicating a systemic anti-tumor effect.  
Conclusions: mEHT induced caspase-dependent programmed cell death and the release of stress 
associated DAMP proteins in colorectal cancer allografts can provoke major immune cell 
infiltration. Accumulating antigen presenting dendritic cells and T-cells are likely to contribute to the 
ongoing tumor destruction by an immunogenic cell death mechanism both locally and through 
systemic effect at distant tumor sites. 
Key words: modulated electro-hyperthermia, colorectal cancer, apoptosis, damage signaling, immunogenic cell 
death, systemic effect. 
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Introduction 
Colorectal cancer is one of the most common 
fatal malignancies worldwide affecting more than 1.2 
million new patients every year [1, 2]. At least 50% of 
the cases relapse after surgical removal of the tumor 
without distant metastasis and 20% of colorectal 
cancers have distant metastasis at the time of 
diagnosis [3]. Though the 5 year survival of localized 
cancer is over 90%, it is sharply reduced to <12% in 
patients with distant tumor spread [4]. Since 
traditional treatment options of colorectal cancer are 
limited, boosting of the host’s immune response offers 
a promising addition as shown by clinical trials 
utilizing immune modulation therapies [2, 5]. We 
earlier revealed that modulated electro-hyperthermia 
(mEHT) treatment can effectively damage colorectal 
cancer allografts in immunocompromised mice and 
provoke the release of damage associated molecular 
pattern (DAMP) signals, which can potentially 
promote immunogenic tumor cell death [6, 7]. In this 
study we investigated the mEHT related tumor stress 
and immune response in cancer allografts of 
immunocompetent mice both locally and at distant 
tumor sites after combining mEHT with a T-cell 
promoting agent. 
Immunogenic cell death (ICD) can be stimulated 
by the spatiotemporal occurrence of DAMP signals 
during programmed cell death as a result of diverse 
cancer treatments [8]. DAMP signals support the 
activation of NK-cells and the functional maturation 
of professional antigen presenting cells (APC) in 
combination with tumor antigens and trigger 
cell-mediated antitumor immune responses [9]. 
Several oncological treatments can induce DAMP 
signals with slightly diverse patterns including 
chemotherapeutic agents, such as anthracyclines, 
oxaliplatin or cyclophosphamide; γ-irradiation, or 
anti-epidermal growth factor receptor (EGFR) specific 
target therapy [8, 10]. 
Modulated EHT treatment is a non-invasive 
complementary to chemo- and radiation tumor 
therapy using electromagnetic field generated by 
amplitude modulated 13.56 MHz radiofrequency. The 
electromagnetic field, which can instantly penetrate 
into cancer lumps, can induce heat shock response at 
controlled 42oC, besides interfering with cell 
membrane lipid rafts gathering receptor molecules 
[11]. Tumor selectivity of mEHT is linked to the 
elevated glycolysis (also known as the Warburg 
effect), ion concentration and permittivity of tumors 
compared to adjacent normal tissues [12]. In HT29 
human colorectal cancer grown in immunodeficient 
BALB/c nu/nu mice we previously confirmed a 
significant, dominantly caspase-independent, AIF 
(apoptosis inducing factor) mediated tumor 
destruction by mEHT [7]. The programmed cell death 
response was accompanied by the progressive release 
of DAMP signals and we observed the accumulation 
immature immune cells suggestive of an ICD reaction 
[6]. In line with this, mEHT pre-treatment has recently 
been described to augment tumor antigen primed 
dendritic cell immunotherapy through supporting 
T-cell, macrophage and eosinophil leukocyte invasion 
of CT26 murine colorectal cancer allografts [13]. 
Extracts from Marsdenia tenacissima (MTE) herb 
has been used as a complementary to chemo- and 
targeted receptor tyrosine kinase (RTK) inhibitory 
therapy (e.g. with gefitinib) of lung, gastric and liver 
cancers [14]. In non-small cell lung cancer MTE 
provoked apoptosis in combination with cisplatin and 
also suppressed EGFR signaling [15, 16]. Also, MTE 
treatment in esophageal cancer contributed to the 
temporary inhibition of MAPK pathway through 
G0/G1 arrest [14]. High pressure liquid 
chromatography-mass spectrometry (HPLC-MS) 
analysis of MTE extracts detected massive chlorogenic 
acid levels [17]. Chlorogenic acid has been 
demonstrated to support the efficacy of 5-fluorouracil 
treatment in hepatocellular carcinoma through 
inhibiting ERK1/2 signaling [18], and tumor 
infiltration by T-cells [19]. 
In this study, we investigated the mEHT induced 
tumor cell death in C26 colon cancer allografts using 
immunocompetent BALB/c mice, with particular 
focus on stress responses, DAMP signaling and 
anti-tumor immune response. We also tested the 
effect of mEHT after MTE administration to see how 
combined therapy affects local and distant tumor 
sites. 
Materials and Methods 
Tumor model 
C26 murine colorectal adenocarcinoma cell line 
(CLS Cell Lines Service GmbH, Eppelheim, Germany, 
#400156) was grown in RPMI 1640 + GlutaMax, 
medium including 10% heat inactivated fetal calf 
serum (FCS) and 5% streptomycin-penicillin (5000 
units penicillin and 5 mg streptomycin/ml). Cells 
were released from a sub-confluent monolayer using 
0.25% trypsin and 0.22 mg/ml 
ethylenediaminetetraacetic acid (EDTA) for 5 min and 
suspended in a serum free medium to reach the 
required 107 cell/ml concentration. All reagents were 
from GIBCO (Invitrogen, Carlsbad, CA). 
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BALB/c mice (females) were maintained in 
sterile environment, kept on sterilized food and water 
ad libitum under 12 h dark/12 h light cycles. The C26 
cell line was subcutaneously injected with 1 million 
cells/100 µl into both femoral regions of 6 week old 
BALB/c mice, which were kept for 14 days until the 
diameter of symmetrical tumor implants reached ~1.5 
cm diameter. 
Laboratory animals were kept and treated in 
compliance with the Hungarian Laws No. 
XXVIII/1998 and LXVII/2002 on the protection and 
welfare of animals, and the animal welfare 
regulations of the European Union. The study was 
approved by the Governmental Ethical Committee 
under No. SzIE ÁOTK MÁB 233/2012 and No. SzIE 
ÁOTK MÁB 26/2013. 
Treatments 
Only the right leg tumors were treated with 
mEHT (mEHTright) of the symmetrical C26 implants 
using plan-parallel electric condensers embracing the 
tumors (Figure 1A). The left-leg tumors served both 
for untreated internal controls (mEHTleft) and for 
monitoring the potential systemic effect of the 
treatment options tested. A rectangular grounded 
(lower) aluminum electrode of 72.0 cm2 (kept at 37 °C) 
was below the animals and a 2.5 cm2 round 
copper-silver-tin coated flexible textile electrode was 
overlaid on the tumors, which were cooled under 
control using a wet pad. Electromagnetic heating was 
generated by capacitive coupled, amplitude 
modulated 13.56 MHz radiofrequency (LabEHY, 
Oncotherm kft, Budaors, Hungary). Animals were 
treated under 100 mg/kg ketamine and 10 mg/kg 
xylazine anesthesia, with a single shot of mEHT for 30 
min using 1-3W average power. Intratumoral 
temperature was measured with optical sensors 
(Luxtron FOT Lab Kit, LumaSense Technologies, Inc. 
CA) and kept at ~42°C (+/- 0.5°C) (Figure 1B). The 
subcutaneous temperature under the electrode was 
kept at ~40 °C and the rectal temperature at ~37°C. 
Marsdenia tenacissima ingredients extracted 
using warm water followed by alcohol precipitation 
(MTE, Xiao-Ai-Ping, Sanhome Pharmaceutical Co., 
Nanjing, China). Mice were injected with 7.5 ml/kg 
extract intraperitoneally (i.p.). In the combined 
treatment group, MTE administration was followed 
30 min later by mEHT treatment of the right-leg 
tumors (mEHT+MTEright), as described above. In 
sham treated animals the experimental conditions 
were the same as in mEHT groups except that the 
electric circuit was off. Tumor samples were collected 
from at least 3 animals at each time point from each 
group 12, 24, 48 and 72 h after treatment following the 
sacrificing of mice by cervical dislocation. Excised 
tumors were fixed in 10% formalin, dehydrated and 
embedded into paraffin wax.  
Measuring mEHT related tumor destruction  
Serial cross sections of 4 µm thickness were cut 
from whole tumor blocks were used both for 
hematoxylin and eosin (H&E) and immunostaining. 
H&E stained slides were digitalized using 
Pannoramic Scan and analyzed with the HistoQuant 
module of Pannoramic Viewer software (all from 
3DHISTECH, Budapest, Hungary) based on image 
color and intensity segmentation. The whole tumor 
area (W) was correlated with the damaged (paler) 
tumor tissue (D) for calculating the tumor destruction 
ratio (TDR=W/D) (Figure 1C). 
Immunohistochemistry 
Both whole cross sections and tissue microarrays 
(TMA) were used for immunohistochemistry. Three 
representative cores of 2 mm diameter taken from 
standard areas of each tumor samples were collected 
into TMA blocks. Two cores from the border between 
degraded and intact tumor regions and 1 from the 
degraded tumor center based on H&E stained slides 
using the computer-driven TMA Master 
(3DHISTECH). For antigen retrieval dewaxed, 
rehydrated and endogenous peroxidase-blocked (20 
min in 1:60; H2O2:methanol) slides were heated at 
~100oC for 40 min using microwave oven (Whirlpool, 
Benton Harbor, MI) either in citrate buffer pH 6.0 (0.01 
M sodium citrate-citric acid) or in Tris-EDTA (TE) 
buffer pH 9.0 (0.1 M Trisbase and 0.01 M EDTA) 
followed by a blocking in 0.1 M Tris-buffered saline 
(TBS, pH7.4) containing 5% bovine serum albumin 
(BSA) and 0,1 % sodium-azide (all from 
Sigma-Aldrich, St Luis, MO) for 20 min. Then, 
sections were incubated in a humidity chamber at 
room temperature overnight (16 h) using the 
antibodies and conditions listed in Table 1. For 
immunofluorescence Alexa Fluor 546 (orange-red) 
coupled anti-rabbit Ig (1:200) was used for 90 min. 
Cell membranes were highlighted with a wheat germ 
agglutinin (WGA) alexa fluor 488 conjugate (1:200) 
and cell nuclei were stained blue with 4’, 
6-diamidino-2-phenylindole (DAPI). All fluorescence 
probes were from Invitrogen/Molecular Probes 
(Carlsbad, CA, USA). For immunoperoxidase staining 
the labelled polymer-peroxidase anti-rabbit Ig 
detection system (Dako, Glostrup, Denmark) was 
applied for 30 min and the reactions were developed 
using DAB/hydrogen peroxide kit 
(Leica-NovoCastra, Newcastle Up-on-Tyne, UK). 
Between incubation steps the slides were washed 3x3 
minutes in TBS (pH 7.4) buffer. Stained slides were 
digitalized and the immunofluorescence reactions 
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were evaluated using image (color, intensity and size) 
segmentation based software tools HistoQuant and 
CellQuant (3DHISTECH). Relative mask areas (rMA) 
representing positive immunoreactions were 
calculated by dividing stained area with the whole 
annotation area for cleaved-caspase-3, HMGB1, CD3 
and S100 staining. For calreticulin and Hsp70 staining 
the number of biomarker positive cells was counted in 
5 representative microscopic fields (FOV) at x40 
objective magnification in each sample at each time 
point and case. The number of cytoplasmic 
cytochrome c positive and nuclear FoxP3 positive 
cells was counted in 3 FOV and 5 FOV/sample at x50 
objective magnification, respectively. 
TUNEL assay 
Terminal deoxynucleotidyl transferase nick end 
labeling (TUNEL, Alexa Fluor 488 Assay, Invitrogen) 
assay was used according to manufacturer’s 
instructions. This assay is based on the detection and 
linking of DNA nick ends by terminal 
deoxynucleotidyl transferase (TdT) with 
fluorochrome labeled deoxyuridine triphosphate 
(dUTP) nucleotides. Labeling of cell nuclei is 
proportional with the amount of fragmented DNA as 
a result of programmed cell death. Briefly, dewaxed 
and rehydrated slides were heated in a citrate based 
pH 6.0 antigen unmasking solution (H-3300, Vector 
Lab, Burlingame, CA) for 45 minutes using 
microwave oven (Whirlpool, as above). Then slides 
were incubated at 37°C for 60 min with a cocktail of 
alkyne substituted dUTP and TdT followed by the 
fluorochrome for 30 min at room temperature which 
coupled to dUTP under copper (I) catalysis. Slides 
were digitalized using Pannoramic Scan after nuclear 
DNA was stained with DAPI. The TUNEL positive 
cells were counted at x100 objective magnification in 5 
FOV in each sample. 
Statistical analysis 
The SPSS v.20 package was used for statistics 
(IBM, New York, NY). Since our data did not show 
normal distribution the non-parametric 
Kruskal-Wallis test was used for analyzing 
significance among groups, followed by Dunn’s post 
hoc test with Bonferroni correction to see pairwise 
statistical significance between groups. Significance 
was declared at p<0.05, or less after correction. 
Results 
mEHT induced programmed tumor cell death 
Tumor destruction ratio (TDR) calculated by 
dividing the damaged areas with the whole tumor 
areas (Figure 1C-D), measured in H&E stained digital 
slides, was significantly higher in mEHT treated 
(mEHTright) than untreated sides (mEHTleft) or sham 
control tumors between 24-72 h post-treatment 
(Figure 1E-F). Combination therapy (mEHT+MTE) 
led to tumor damage not only in the treated right 
tumors (mEHT+MTEright) but also in the untreated left 
tumors (mEHT+MTEleft) within the same time-frame 
(Figure 1G). Kruskal-Wallis test proved highly 
significant differences (p<0.001) among groups 24 h 
(χ2(5)=26.081), 48 h (χ2(5)=20.911) and 72 h 
χ2(5)=28.297) post-mEHT treatment. The effect of MTE 
administration alone was not significant.  
Nuclear chromatin condensation and 
widespread apoptotic bodies indicated mEHT 
induced programmed cell death response (Figure 
1D), which was confirmed by elevated DNA 
fragmentation from 24 h post-treatment (χ2(5)=72.415, 
p<0.001) (Figure 1H). Post hoc test revealed 
significantly elevated TUNEL positivity in: mEHTright 
vs. shamright and shamleft; in the mEHT+MTEright or 
mEHT+MTEleft vs. sham controls and mEHTleft 
(Figure 1I).  
 
 
Table 1. Antibodies and conditions used for immunohistochemistry and immunofluorescence. (T-E tris-EDTA) 
Antigen Type Reference no. Dilution Antigen retrieval Vendor 
AIF Rabbit, pAb #4642 1:25 T-E Cell Signaling 
Bax Rabbit, pAb #HPA027878 1:50 T-E Sigma 
Calreticulin Rabbit, pAb  #12238 1:200 T-E Cell Signaling 
CD3 Rabbit, pAb  #IS503 1:2 T-E DAKO 
Cleaved caspase-3 Rabbit, pAb #9664 1:100 Citrate Cell Signaling 
Cleaved caspase-8 Rabbit, pAb #8592 1:100 T-E Cell Signaling 
Cytochrome c Rabbit, pAb  #4280 1:50 T-E Cell Signaling 
FoxP3 Rat, pAb  #14-5773 1:600 T-E eBioscience 
HMGB1 Rabbit, pAb  #6893 1:200 Citrate Cell Signaling 
Hsp70 Rabbit, pAb  #4872 1:50 T-E Cell Signaling 
S100 Rabbit, pAb  #RB-9018 1:500 T-E Thermo 
Vendor specification: Cell Signaling (Danvers, MA, USA), Thermo (Waltham, MA, USA), Dako (Glostrup, Denmark), eBioscience (San Diego, CA, USA), Sigma (St. Louis, 
MO, USA); T-E: Tris-EDTA, pH 9.0. 
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Figure 1. mEHT induced tumor destruction and DNA fragmentation. Experimental model of mEHT treatment (A). Temperature curves during treatment 
(B). Tumor destruction ratio (TDR) calculated as the damaged per whole tumor area in hematoxylin-eosin stained sections was significantly elevated after mEHT 
treatment of C26 colorectal cancer allografts (C). Chromatin condensation and apoptotic bodies (arrowheads) are typical signs of apoptosis (D). Elevated TDR both 
in the mEHT treated right-leg tumors compared to the untreated left sides or sham controls in monotherapy, and in both tumor sides after combing mEHT and MTE 
(mEHT+MTE) compared to the sham controls, 24 h after treatment (E). Progressive tumor damage both after single (F) and combined mEHT+MTE treatments (G). 
Significantly elevated numbers of TUNEL positive cell nuclei (green) in the mEHT-treated (right) tumor (H), and in both sides of the mEHT+MTE combination group 
compared to sham controls 24 h post-treatment (I). p**<0.001. Scale bar shows 2 mm on C, 100 µm (left) and 10 µm (right) on D; and 20 µm (H-I). 
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Mechanism of mEHT induced programmed 
tumor cell death 
mEHT treatment induced the significant 
mitochondrial translocation of bax protein and the 
cytoplasmic release of cytochrome c between 12-24 h 
(χ2(5)=11,989, χ2(5)=14,497, p<0.05) in the treated 
(mEHTright) tumors either after single or combined 
mEHT treatment (Figure 2A-B). Cytochrome c 
became significantly delocalized (χ2(5)=11,943, 
p<0.05) also in the mEHT untreated (left-leg) tumors 
of the combined mEHT+MTE group between 48-72 h 
(not shown). Major elevation of cleaved/activated 
caspase-3 positive cell numbers were seen from 12 h 
post-treatment compared to sham controls 
(χ2(5)=9,842, p<0.05) (Figure 2C-D). Overlapping 
cleaved caspase-8, -caspase-3 and TUNEL positive cell 
fractions were significantly elevated in the apoptotic 
tumor regions including the intact-damaged marginal 
zone, particularly at advanced stages, 48-72 h 
post-mEHT treatment (Figure 2E-F). These findings 
are consistent with the activation of 
caspase-dependent extrinsic and intrinsic apoptotic 
pathways. After treatment the nuclear Ki67 protein 
expression disappeared completely from tumor cells 
which showed minor morphological signs of 
apoptosis (Figure 3). 
There was no statistical difference in nuclear 
apoptosis inducing factor (AIF) levels between the 
treated and untreated tumors (not shown). 
mEHT induced damage associated molecular 
pattern (DAMP) signals  
Massive cytoplasmic to cell-membrane 
relocalization of calreticulin was observed from 12 h 
post-treatment (χ2(5)=44.720, p<0.001). Pairwise 
statistical analysis confirmed significant cell 
membrane concentration in mEHTright (mEHT treated) 
vs. mEHTleft and sham control tumors; and in 
mEHT+MTEright or mEHT+MTEleft vs. mEHTleft and 
sham control tumors (Figure 4A-B). 
This was followed by the significant 
cell-membrane accumulation of Hsp70 protein in the 
mEHT-treated groups peaking at 48 h post-treatment 
(χ2(5)=54.912, p<0.001). Pairwise significance was seen 
in mEHTright vs. mEHTleft and sham control tumors; 
and in mEHT+MTEright or mEHT+MTEleft vs. mEHTleft 
and sham control tumors (Figure 4C-D). 
Also, significant nuclear to cytoplasmic release 
or complete loss in the damaged areas of HMGB1 
protein was seen at 48 h post-mEHT treatment 
(χ2(5)=12.969, p=0.024). Post hoc test confirmed 
significant disappearance of HMGB1 in mEHTright vs. 
sham controls; and in mEHT+MTEleft vs. mEHTleft 
tumors (Figure 4E-F).  
mEHT induced tumor infiltration by antigen 
presenting cells and T-cells 
DAMP signal sequence was accompanied by the 
massive tumor infiltration by S100 positive APC from 
48 h post-treatment (χ2(5)=12.483, p=0.029). Post hoc 
test revealed significant numbers of APC in mEHTright 
vs. mEHTleft and shamright and shamleft tumors; and in 
mEHT+MTEright vs. sham tumors (Figure 5A-B). Also, 
significant numbers of CD3 positive T-cells infiltrated 
the treated tumors with a peak at 72 h post-mEHT 
treatment (χ2(5)=14.156, p=0.015) (Figure 5C). 
Pairwise testing confirmed significantly more T-cells 
in mEHTright vs. mEHTleft tumors; and in 
mEHT+MTEright vs. shamleft and shamright tumors 
(Figure 5C-D). APC and T-cell invasion also showed a 
nearly significant trend between mEHT+MTEleft and 
sham control tumors. A dense ring of T-cell invasion 
was seen in the margin between the damaged and 
“intact”-looking tumor regions, with the latter also 
infiltrated heavily (Figure 5E). FoxP3 positive T-cells 
were rare and their number did not differ between 
treated and untreated tumors. 
Discussion 
Previously we showed that the mEHT can 
trigger a programmed cell death response in HT29 
human colorectal cancer xenografts of 
immunocompromised mice, which was dominantly 
mediated by caspase independent AIF activation [7]. 
This was accompanied by the translocation and 
release of DAMP signal elements relevant to inducing 
ICD and the tumor infiltration by immature immune 
cells [6]. In the current study, C26 colorectal cancer 
allografts grown in immunocompetent mice were 
used to test mEHT induced cell stress, programmed 
cell death and anti-tumor immune responses. Here 
also, we detected apoptosis mediated tumor damage, 
which however, followed a caspase-dependent 
subroutine. It seems that the preferred programmed 
cell death pathway after mEHT treatment is rather 
depend on the inherent genetic and epigenetic 
makeup of the given tumor cell line, than the 
treatment itself. This view is supported by detecting 
the same death pathways as after mEHT treatment in 
small damaged areas, probably induced by hypoxia, 
in the untreated sham tumors both in the HT29 and 
C26 models. In this study, the mEHT induced DAMP 
signal sequence was followed by significant APC and 
T-cell invasion of the treated tumors, which was also 
seen in the untreated contralateral neoplasms when 
mEHT was delivered together with MTE, a T-cell 
promoting agent (summarized in Figure 6). These data 
suggest that besides its loco-regional effect mEHT can 
also contribute to tumor damage distant from the 
directly targeted regions. 
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Figure 2. mEHT induced pro-apoptotic factors. Mitochondrial cytochrome c in untreated tumors show significant cytoplasmic (green, immunofluorescence 
after mEHT treatment (A) in parallel with the mitochondrial translocation of bax protein (insets in A, brown immunoperoxidase) in 12h samples (p*<0.05) (B). At 
the same time, cleaved caspase-3 positive cells (brown, immunoperoxidase) are also significantly more common at both tumor sides after combined (mEHT+MTE) 
treatment (D). Overlapping cleaved caspase-8 positive (brown, immunoperoxidase) (E), TUNEL (green fluorescence) and cleaved caspase-3 (brown) positive cell 
fractions (F) concentrated in damaged tumor regions proved both extrinsic and intrinsic caspase dependent apoptosis, 48 h and 72 h after treatment, respectively. 
Scale bars, A and C: 20 µm; E and F: 100 µm. 
 
It has already been revealed that mEHT 
treatment can more effectively destroy tumor cells 
than conventional hyperthermia at the same (42°C) 
intratumoral temperature [20]. This and all of our 
earlier works suggest that modulated electric field can 
instantly penetrate deep into tumors and provoke 
tumor damage spreading inside-out from tumor 
centers [6, 7, 20]. It can efficiently mediate an 
irreversible cell stress by inducing heat shock and 
affecting charged molecules particularly in tumor cell 
membranes [11]. In human cancer therapy, mEHT 
(oncothermia; and traditional hyperthermia too) is 
used in sequentially repeated treatment modules, 
usually alternating either with radio- or 
chemotherapy. Experimentally, so far we only 
characterized the effects of single mEHT treatment. 
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Therefore, in our present model, for standardizing 
single treatment, we precisely measured and kept 
intratumoral temperature at 42oC. We demonstrated 
that mEHT treatment caused significant destruction 
of C26 colorectal cancer cells by inducing apoptosis 
confirmed by chromatin condensation and nuclear 
DNA fragmentation. C26 cell line form aggressive 
tumors in vivo, which show almost 100% proliferation 
index by detecting Ki67 protein a general cell cycle 
marker expressed from G1- to the end of M-phase 
[21]. Furthermore, we showed that early apoptotic 
commitment induced by mEHT can result in the 
complete blockade of the cell cycle regulation 
machinery indicated by the loss nuclear Ki67 
expression.  
The progressive accumulation of DNA 
fragmentation and apoptotic bodies between 12-72 h 
post mEHT treatment was consistent with a 
programmed cell death response without obvious 
necrosis. The significant tumor damage caused by 
mEHT treatment proved to be caspase-dependent 
indicated by the massive expansion of the 
cleaved/activated caspase-3 positive apoptotic cell 
fractions. The upregulation of cleaved/activated 
caspase-8 protein besides the mitochondrial 
translocation of bax and the mitochondrial release of 
cytochrome c confirmed the activation of both the 
extrinsic and intrinsic caspase dependent pathways 
[22]. Elevated apoptotic signaling detected initially, 
between 12-24 h, only in the mEHT treated tumors 
became bilateral by 48 h post-treatment in 
mEHT+MTE treated animals. This finding suggests 
that apoptosis can be provoked by mEHT both 
directly and later on through mediators which recruit 
the immune system (see Figure 6). The latter may 
involve factors discharged by damaged tumor cells 
and those of MTE extract leading to a systemic effect 
on distant tumor sites.  
Tumor treatment can contribute to the 
elimination of cancer cells through interactions 
between immune-independent (initial apoptosis) and 
immune-dependent (activation of immune response) 
pathways [23]. Immunogenic tumor cell death 
response can extend and maintain the treatment 
induced primary apoptotic tumor damage. ICD can 
be triggered by DAMPs including extracellular 
release of HMGB1 and ATP which act similar to 
cytokines [24]. It is also supported by the cell 
membrane localization and access by antigen 
presenting and immune cells of the chaperons Hsp70 
and calreticulin [6]. Conventional hyperthermia can 
induce only partial DAMPs in tumors mainly through 
Hsp70 release which alone is less efficient in 
supporting APC maturation as well as NK and 
cytotoxic T-cell functions [25, 26, 27]. Complex DAMP 
signals can activate APC by promoting the uptake and 
presentation of tumor antigens through Toll-like-, 
purinergic- and pattern recognition receptors for 
enhancing tumor-specific T-cell response [23]. In line 
with our results in immunocompromised tumor 
model [6], mEHT in this study also induced complex 
DAMP signals including calreticulin, HSP70 and 
HMGB1 release. The potential immune stimulatory 
effect of these signals was supported by our finding of 
progressive tumor infiltration by S100 positive APC 
and CD3 positive T-cells in immunocompetent mice 
with only negligible number of FoxP3+ immune 
inhibitory T-cells. Though elevated tumor damage, 
DAMP signaling and immune cell infiltration was 
frequently seen in the contralateral (left) tumors after 
single mEHT treatment, this became significant only 
after combined mEHT+MTE treatment in the mEHT 
untreated left tumors. 
 
 
Figure 3. mEHT induced blocking of cell cycle progression. Nuclear Ki67 positivity indicating tumor cell proliferation is ceased in the mEHT damaged central 
tumor regions (left), even in cells showing only early signs of apoptosis. Gradually higher magnifications (middle and right). The lymphoid germinal center (middle, 
arrowhead) serves for Ki67 positive control. Scale bar shows 2 mm on left, 200 µm on middle and 60 µm on right images. 
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Figure 4. mEHT induced damage signaling. Release of calreticulin (red) protein from the mitochondria and colocalization with the cell membrane marker 
WGA (green) confirms its membrane accumulation (yellow) after mEHT treatment (A). Significantly increased proportion of tumor cells with overlapping WGA and 
calreticulin reactions (arrowheads) in both treatment groups (p**<0.001) compared to sham controls (B). Elevated intracytoplasmic Hsp70 protein (red) in overlap 
with the cell membrane WGA (green) 48h after treatment. The number of Hsp70 positive cells was significantly increased (p**<0.001) in the mEHTright and in both 
tumors of mEHT+MTE groups compared to sham controls (D). Early nuclear to cytoplasmic release of HMGB1 (red) group 48 h after treatment (E). The proportion 
of HMGB1 negative areas indicating extracellular release were significantly lower (p*<0.05) in the mEHTright and in both tumor sides of mEHT+MTE groups compared 
to sham controls (F). Scale bar in large images shows 20 µm, and 10 µm in the insets. 
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Figure 5. mEHT induced tumor infiltration by immune cells. Significantly elevated numbers of S100 positive (brown) antigen presenting dendritic cells (APC) 
in the mEHTright tumors, and in both tumor sides of the mEHT+MTE combined group 48 h after treatment (A), as summarized in a graph (B). Increase in T-cell 
numbers also proved to be significant (p*<0.05) in the mEHTright tumors, and in both tumor sides of the mEHT+MTE combined group 72 h after treatment (C), shown 
also in a graph (D). Massive T-cell infiltration rim separates damaged central tumor regions from the intact periphery (E), which latter is also heavily infiltrated as seen 
at higher magnification (middle), with only scant FoxP3+ T cells (right). Scale bars in A-B and D-E: 40 µm. Scale bar in C-left: 2 mm, middle and right: 100 µm. 
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Figure 6. Summary drawing on mEHT induced anti-tumor damage mechanisms. Upper panel. Heat stress at 42oC and direct effect of electric field on 
dipole molecules both in the extracellular matrix (ECM) and the tumor cell membrane induce caspase-dependent apoptosis resulting in DNA fragmentation. The 
concomitant release of DAMP signals (Hsp70, calreticulin and HMGB1) support the maturation of antigen presenting cells (APC), which activate cytotoxic T-cells for 
mediating a secondary, immunogenic cell death (ICD) response. Systemic mEHT effect is possibly facilitated by MTE promoted T-cell migration/activation. Lower 
panel sums up semiquantitatively how mEHT induced pathways, tumor destruction effect and cell cycle arrest are manifested after using different treatment modules. 
 
Similar to our results, local mEHT treatment, in 
combination with antigen-primed syngeneic APC 
injection, significantly inhibited the growth of CT26 
tumors (similar to C26 but from different vendor) and 
protected animals from developing new tumors after 
CT26 re-challenge [13]. This intervention primed 
IFN-γ secretion and supported the recruitment of both 
the innate immunity and the adaptive cytotoxic T-cell 
mediated immunity. A similar mEHT primed APC 
treatment of squamous cell carcinoma allografts also 
induced elevated numbers of S100 positive APC and 
CD8 positive cytotoxic T-cells in line with the 
inhibition of tumor growth both in the treated and 
distant tumor sites [28]. In agreement with our results, 
mEHT (when combined with APC therapy) did not 
influence the number of the immune-inhibitory FoxP3 
positive regulatory T-cells [29]. Thus, massive CD3 
positive T-cell infiltration with insignificant number 
of FoxP3 positive regulatory T-cells, can mediate an 
effective anti-tumor immune response [26, 29]. This 
was supported by the progressive nature and positive 
correlation between tumor damage and immune cell 
infiltration in our present study.  
MTE treatment has been demonstrated to 
support the cellular immune response. MTE 
administration synergized with the growth inhibitory 
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and apoptosis inducing effect of cisplatin in Lewis 
lung cancer xenografts and increased the number of 
tumor infiltrating CD8 positive T-cells and the 
expression of interferon-γ, perforin-1, and 
granzyme-B [16]. It also contributed to the 
suppression of growth of EGFR inhibitor resistant, 
K-ras and EGFR-mutant non-small cell lung cancer 
cells through hampering downstream RTK signaling 
pathways (Akt and MAPK) [15]. This effect was 
primarily attributed to chlorogenic acid identified in 
MTE by enhancing IFN-γ, IL-2, IL-12, MCP-1 levels 
and promoting the recruitment of TH1 lymphocytes, 
as well as stimulating T-lymphocyte, NK-cell and 
macrophage functions [19, 30]. The systemic effect of 
loco-regional cancer therapy, also known as abscopal 
effect, which was confirmed e.g. after chemotherapy 
or γ-irradiation, is most probably mediated by the 
immune system [31]. Therefore, both published 
reports and our data suggest that MTE can contribute 
to APC and T-cell recruitment and tumor infiltration 
in synergy with DAMP signals and tumor antigen 
release induced by mEHT. However, the accurate 
mechanism of action and the messengers involved 
need to be further clarified in molecular and 
functional studies. 
In conclusion, mEHT treatment can cause 
irreversible cell stress and the blockade of tumor cell 
cycle leading to caspase-dependent programmed cells 
death in C26 colorectal cancer allografts of 
immunocompetent mice. DAMP signals released 
from mEHT damaged cells are associated with tumor 
infiltration by APC and T-cells, which are likely to 
contribute to the ongoing tumor damage. Local mEHT 
treatment can also facilitate a systemic antitumor 
effect in combination with a T-cell promoting agent. 
The contribution of MTE derived chlorogenic acid in 
the immune response need to be further elucidated.  
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